Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Robert Harold Rubin, M.D.

TitleGordon and Marjorie Osborne Professor of Health Sciences and Technology
InstitutionMassachusetts Institute of Technology
DepartmentHealth Sciences and Technology
AddressBrigham and Women's Hospital
PBB-A-316, ID Division
75 Francis St
Boston MA 02115
Phone617/732-8716
Fax617/582-6111
Other Positions
TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Marty FM, Hirsch HH, Rubin RH. Transplant infectious disease as a subspecialty: does outlining how we train define who we are? Transpl Infect Dis. 2010 Jun; 12(3):187-9.
    View in: PubMed
  2. Kallenberg MH, Gill RR, Factor RE, Bryar JM, Rubin RH, Jacobson FL, Marty FM. Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies. Acad Radiol. 2009 Nov; 16(11):1408-15.
    View in: PubMed
  3. Benjamin J, Moldavsky S, Lee J, Rubin R. Prevalence of heparin-induced antibody in African-American hemodialysis patients--comparison to non-dialysis patients. Clin Nephrol. 2009 Mar; 71(3):263-6.
    View in: PubMed
  4. Rubin RH, Hirsch HH. Transplant infectious disease: a moving target. Transpl Infect Dis. 2008 Feb; 10(1):1-2.
    View in: PubMed
  5. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis. 2007 Nov 1; 45(9):1132-40.
    View in: PubMed
  6. de Pauw BE, Rubin RH. The value of randomized clinical trials for daily clinical practice. Transpl Infect Dis. 2007 Sep; 9(3):173-4.
    View in: PubMed
  7. Rubin RH. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'. Curr Opin Infect Dis. 2007 Aug; 20(4):399-407.
    View in: PubMed
  8. de Pauw BE, Rubin RH. Individualization in the management of fungal disease in the transplant recipient. Transpl Infect Dis. 2007 Jun; 9(2):87-8.
    View in: PubMed
  9. de Pauw B, Rubin RH. Principles of antimicrobial therapy in the transplant recipient. Transpl Infect Dis. 2007 Mar; 9(1):1-2.
    View in: PubMed
  10. Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, Troke PF, Denning DW, Bennett JE, de Pauw BE, Rubin RH. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007 Feb 1; 44(3):373-9.
    View in: PubMed
  11. Rubin RH. Surgical wound infection: epidemiology, pathogenesis, diagnosis and management. BMC Infect Dis. 2006; 6:171.
    View in: PubMed
  12. Qamar AA, Rubin RH. Poorer outcomes for recipients of heart allografts from HCV-positive donors: opening the silos. JAMA. 2006 Oct 18; 296(15):1900-1.
    View in: PubMed
  13. Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T. Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis. 2006 Oct 15; 43(8):1031-9.
    View in: PubMed
  14. Marty FM, Rubin RH. The persistent challenges of bacterial infections in the transplant recipient. Transpl Infect Dis. 2006 Sep; 8(3):125-7.
    View in: PubMed
  15. Silva H, Sungar E, Kleinstiver SJ, Rubin RH. Opportunities and challenges for clinical and cardiovascular research in Latin America. Am J Ther. 2006 Jul-Aug; 13(4):309-14.
    View in: PubMed
  16. de Pauw BE, Rubin RH. Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy. Transpl Infect Dis. 2006 Mar; 8(1):1-2.
    View in: PubMed
  17. Rubin RH, Gilman MD, Kradin RL. Case records of the Massachusetts General Hospital. Case 1-2006. A 64-year-old male lung-transplant recipient with fever, cough, hemoptysis, and abdominal pain. N Engl J Med. 2006 Jan 12; 354(2):180-7.
    View in: PubMed
  18. Marty FM, Rubin RH. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy. Transpl Int. 2006 Jan; 19(1):2-11.
    View in: PubMed
  19. Baden LR, Rubin RH. Darwinian competition and the pathogenesis of opportunistic infection in the transplant recipient. Transpl Int. 2005 Nov; 18(11):1223-5.
    View in: PubMed
  20. Rubin RH. Management of tuberculosis in the transplant recipient. Am J Transplant. 2005 Nov; 5(11):2599-600.
    View in: PubMed
  21. Patterson TF, Boucher HW, Herbrecht R, Denning DW, Lortholary O, Ribaud P, Rubin RH, Wingard JR, DePauw B, Schlamm HT, Troke P, Bennett JE. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Clin Infect Dis. 2005 Nov 15; 41(10):1448-52.
    View in: PubMed
  22. Hadigan C, Kamin D, Liebau J, Mazza S, Barrow S, Torriani M, Rubin R, Weise S, Fischman A, Grinspoon S. Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. Am J Physiol Endocrinol Metab. 2006 Feb; 290(2):E289-98.
    View in: PubMed
  23. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Smulders M, Lapetina E, Gemmen E. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med. 2005 Aug 8-22; 165(15):1756-61.
    View in: PubMed
  24. Fischer MA, Winkelmayer WC, Rubin RH, Avorn J. The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis. 2005 Aug 1; 41(3):301-7.
    View in: PubMed
  25. Rubin RH. Transplant infectious disease: a work in progress. Transpl Infect Dis. 2005 Jun; 7(2):49-50.
    View in: PubMed
  26. Jacobson FL, Rubin RH. Art and science in the clinical management of the patient with infection and/or cancer. Transpl Infect Dis. 2004 Dec; 6(4):139-40.
    View in: PubMed
  27. Rubin RH, Marty FM. Principles of antimicrobial therapy in the transplant patient. Transpl Infect Dis. 2004 Sep; 6(3):97-100.
    View in: PubMed
  28. Pereyra F, Rubin RH. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis. 2004 Aug; 17(4):357-61.
    View in: PubMed
  29. Livni E, Berker M, Hillier S, Waller SC, Ogan MD, Discordia RP, Rienhart JK, Rubin RH, Fischman AJ. Preparation and pharmacokinetics of 11C labeled stavudine (d4T). Nucl Med Biol. 2004 Jul; 31(5):613-21.
    View in: PubMed
  30. Rubin RH. The prevention and treatment of infectious disease in the transplant patient: where are we now and where do we need to go? Transpl Infect Dis. 2004 Mar; 6(1):1-2.
    View in: PubMed
  31. Baden LR, Rubin RH. The sentinel chicken revisited: the impact of West Nile virus infection on transplant patients. Transplantation. 2004 Feb 15; 77(3):356-7.
    View in: PubMed
  32. Peters MG, Hann Hw Hw, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df Df, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology. 2004 Jan; 126(1):91-101.
    View in: PubMed
  33. Baden LR, Katz JT, Fishman JA, Koziol C, DelVecchio A, Doran M, Rubin RH. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy. Transplantation. 2003 Dec 15; 76(11):1632-7.
    View in: PubMed
  34. Rubin RH. Diagnosis of opportunistic infections in the transplant patient. Transpl Infect Dis. 2003 Dec; 5(4):157.
    View in: PubMed
  35. Ellerin T, Rubin RH, Weinblatt ME. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum. 2003 Nov; 48(11):3013-22.
    View in: PubMed
  36. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003 Sep; 9(9):543-58.
    View in: PubMed
  37. Rubin RH. Temporal aspects of transplant infectious disease. Transpl Infect Dis. 2003 Jun; 5(2):63-4.
    View in: PubMed
  38. Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis. 2003 May 15; 36(10):1221-8.
    View in: PubMed
  39. Dropulic LK, Rubin RH, Bartlett JG. Smallpox vaccination and the patient with an organ transplant. Clin Infect Dis. 2003 Mar 15; 36(6):786-8.
    View in: PubMed
  40. Rubin RH. Granulomatous infections in the transplant patient. Transpl Infect Dis. 2003 Mar; 5(1):1-2.
    View in: PubMed
  41. Rubin RH, King ME, Mark EJ. Case record of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2003. A 43-year-old man with fever, rapid loss of vision in the left eye, and cardiac findings. N Engl J Med. 2003 Feb 27; 348(9):834-43.
    View in: PubMed
  42. Baden LR, Katz JT, Franck L, Tsang S, Hall M, Rubin RH, Jarcho J. Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Transplantation. 2003 Feb 15; 75(3):339-43.
    View in: PubMed
  43. Rubin RH. Influenza and the transplant recipient. Transpl Infect Dis. 2002 Dec; 4(4):175-6.
    View in: PubMed
  44. Rubin RH. Expanding the envelope: can we increase the organ donor pool through the appropriate application of infectious disease principles? Transpl Infect Dis. 2002 Sep; 4(3):115-6.
    View in: PubMed
  45. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002 Aug 8; 347(6):408-15.
    View in: PubMed
  46. Baden LR, Rubin RH. Fever, neutropenia, and the second law of thermodynamics. Ann Intern Med. 2002 Jul 16; 137(2):123-4.
    View in: PubMed
  47. Rubin RH. The role of new diagnostic tests in transplant infectious disease. Transpl Infect Dis. 2002 Jun; 4(2):57-8.
    View in: PubMed
  48. Alpert NM, Rabito CA, Correia DJ, Babich JW, Littman BH, Tompkins RG, Rubin NT, Rubin RH, Fischman AJ. Mapping of local renal blood flow with PET and H(2)(15)O. J Nucl Med. 2002 Apr; 43(4):470-5.
    View in: PubMed
  49. Rubin RH. The therapeutic prescription for the transplant patient. Transpl Infect Dis. 2002 Mar; 4(1):1-2.
    View in: PubMed
  50. Rubin RH. Overview: pathogenesis of fungal infections in the organ transplant recipient. Transpl Infect Dis. 2002; 4 Suppl 3:12-7.
    View in: PubMed
  51. Rubin RH. The direct and indirect effects of infection in liver transplantation: pathogenesis, impact, and clinical management. Curr Clin Top Infect Dis. 2002; 22:125-54.
    View in: PubMed
  52. Fischman AJ, Alpert NM, Rubin RH. Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action. Clin Pharmacokinet. 2002; 41(8):581-602.
    View in: PubMed
  53. Nagy GS, Rubin RH. Disseminated Mycobacterium avium-intracellulare in a kidney transplant recipient. Transpl Infect Dis. 2001 Dec; 3(4):220-30.
    View in: PubMed
  54. Rubin RH. Infection, antimicrobial resistance, and newly emerging pathogens: the growing role of fungi. Transpl Infect Dis. 2001 Dec; 3(4):187-8.
    View in: PubMed
  55. Mylonakis E, Goes N, Rubin RH, Cosimi AB, Colvin RB, Fishman JA. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation. 2001 Nov 27; 72(10):1587-92.
    View in: PubMed
  56. El Khoury J, Stikkelbroeck MM, Goodman A, Rubin RH, Cosimi AB, Fishman JA. Postmenopausal tubo-ovarian abscess due to Pseudomonas aeruginosa in a renal transplant patient: a case report and review of the literature. Transplantation. 2001 Oct 15; 72(7):1241-4.
    View in: PubMed
  57. Sleath B, Rubin RH, Campbell W, Gwyther L, Clark T. Physician-patient communication about over-the-counter medications. Soc Sci Med. 2001 Aug; 53(3):357-69.
    View in: PubMed
  58. Rubin RH, Schaffner A, Speich R. Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. Clin Infect Dis. 2001 Jul 1; 33 Suppl 1:S1-4.
    View in: PubMed
  59. Peters AS, Feins A, Rubin R, Seward S, Schnaidt K, Fletcher RH. The longitudinal primary care clerkship at Harvard Medical School. Acad Med. 2001 May; 76(5):484-8.
    View in: PubMed
  60. Rubin RH. The use of antimicrobial drugs in transplant patients. Transpl Infect Dis. 2001 Mar; 3(1):1.
    View in: PubMed
  61. Fishman JA, Rubin RH. Solid organ transplantation in HIV-infected individuals: obstacles and opportunities. Transplant Proc. 2001 Feb-Mar; 33(1-2):1310-4.
    View in: PubMed
  62. Tolkoff-Rubin NE, Fishman JA, Rubin RH. The bidirectional relationship between cytomegalovirus and allograft injury. Transplant Proc. 2001 Feb-Mar; 33(1-2):1773-5.
    View in: PubMed
  63. Rubin RH. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities. Clin Transplant. 2001; 15 Suppl 4:11-22.
    View in: PubMed
  64. Rubin RH. Cytomegalovirus in solid organ transplantation. Transpl Infect Dis. 2001; 3 Suppl 2:1-5.
    View in: PubMed
  65. Sullivan KM, Dykewicz CA, Longworth DL, Boeckh M, Baden LR, Rubin RH, Sepkowitz KA. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program. 2001; 392-421.
    View in: PubMed
  66. Rubin RH. Control of hepatitis in the transplant patient: a journey begun--but not there yet. Transpl Infect Dis. 2000 Dec; 2(4):151-2.
    View in: PubMed
  67. Fischman AJ, Bonab AA, Rubin RH. Regional pharmacokinetics of orally administered PET tracers. Curr Pharm Des. 2000 Nov; 6(16):1625-9.
    View in: PubMed
  68. Rubin RH. Prevention of cytomegalovirus infection in organ transplant recipients. Transpl Infect Dis. 2000 Sep; 2(3):99-100.
    View in: PubMed
  69. Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Transpl Infect Dis. 2000 Sep; 2(3):112-7.
    View in: PubMed
  70. Rubin RH. Prevention and treatment of cytomegalovirus disease in heart transplant patients. J Heart Lung Transplant. 2000 Aug; 19(8):731-5.
    View in: PubMed
  71. Rubin RH. Pushing the envelope: transplantation and emerging infections. Transpl Infect Dis. 2000 Mar; 2(1):1.
    View in: PubMed
  72. Turgeon N, Fishman JA, Doran M, Basgoz N, Tolkoff-Rubin NE, Cosimi AB, Rubin RH. Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir. Transpl Infect Dis. 2000 Mar; 2(1):2-10.
    View in: PubMed
  73. Turgeon N, Hovingh GK, Fishman JA, Basgoz N, Tolkoff-Rubin NE, Doran M, Cosimi AB, Rubin RH. Safety and efficacy of granulocyte colony-stimulating factor in kidney and liver transplant recipients. Transpl Infect Dis. 2000 Mar; 2(1):15-21.
    View in: PubMed
  74. Tolkoff-Rubin NE, Rubin RH. Recent advances in the diagnosis and management of infection in the organ transplant recipient. Semin Nephrol. 2000 Mar; 20(2):148-63.
    View in: PubMed
  75. Fishman JA, Doran MT, Volpicelli SA, Cosimi AB, Flood JG, Rubin RH. Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients. Transplantation. 2000 Feb 15; 69(3):389-94.
    View in: PubMed
  76. Rubin RH. Transplantation and the Second Law of Thermodynamics. Transpl Infect Dis. 1999 Dec; 1(4):227-8.
    View in: PubMed
  77. Rubin RH. Cytomegalovirus and transplantation: yesterday, today, and tomorrow. Transpl Infect Dis. 1999 Jun; 1(2):87-8.
    View in: PubMed
  78. Rubin RH, Ikonen T, Gummert JF, Morris RE. The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies. Transpl Infect Dis. 1999 Mar; 1(1):29-39.
    View in: PubMed
  79. Molina-Murphy IL, Palmer EL, Scott JA, Prince MR, Strauss HW, Rubin RH, Fischman AJ. Polyclonal, nonspecific 111In-IgG scintigraphy in the evaluation of complicated osteomyelitis and septic arthritis. Q J Nucl Med. 1999 Mar; 43(1):29-37.
    View in: PubMed
  80. Gilbert JR, Pascual M, Schoenfeld DA, Rubin RH, Delmonico FL, Cosimi AB. Evolving trends in liver transplantation: an outcome and charge analysis. Transplantation. 1999 Jan 27; 67(2):246-53.
    View in: PubMed
  81. Rubin RH. Cytomegalovirus in the transplant population: current issues and future directions. Discussion and consensus points. Transpl Infect Dis. 1999; 1 Suppl 1:40-1.
    View in: PubMed
  82. Rubin RH. Cytomegalovirus in the transplant population: current issues and future directions. An introduction to the symposium. Transpl Infect Dis. 1999; 1 Suppl 1:1-2.
    View in: PubMed
  83. Rubin RH. Importance of CMV in the transplant population. Transpl Infect Dis. 1999; 1 Suppl 1:3-7.
    View in: PubMed
  84. Turgeon N, Fishman JA, Basgoz N, Tolkoff-Rubin NE, Doran M, Cosimi AB, Rubin RH. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy. Transplantation. 1998 Dec 27; 66(12):1780-6.
    View in: PubMed
  85. Fischman AJ, Babich JW, Bonab AA, Alpert NM, Vincent J, Callahan RJ, Correia JA, Rubin RH. Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography. Antimicrob Agents Chemother. 1998 Aug; 42(8):2048-54.
    View in: PubMed
  86. Tolkoff-Rubin NE, Rubin RH. Viral infections in organ transplantation. Transplant Proc. 1998 Aug; 30(5):2060-3.
    View in: PubMed
  87. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998 Jun 11; 338(24):1741-51.
    View in: PubMed
  88. Rubin RH. Opportunities and challenges in infectious disease research for the twenty-first century. Neth J Med. 1998 Jun; 52(6):289-94.
    View in: PubMed
  89. Rubin RH. Cytomegalovirus disease and allograft loss after organ transplantation. Clin Infect Dis. 1998 Apr; 26(4):871-3.
    View in: PubMed
  90. Rubin RH, Fishman JA. A consideration of potential donors with active infection--is this a way to expand the donor pool? Transpl Int. 1998; 11(5):333-5.
    View in: PubMed
  91. Krebs HI, Brashers-Krug T, Rauch SL, Savage CR, Hogan N, Rubin RH, Fischman AJ, Alpert NM. Robot-aided functional imaging: application to a motor learning study. Hum Brain Mapp. 1998; 6(1):59-72.
    View in: PubMed
  92. Christian BT, Babich JW, Livni E, Alpert NM, Bonab AA, Munconi L, Polinski R, Rubin RH, Fischman AJ. Positron emission tomographic analysis of central dopamine D1 receptor binding in normal subjects treated with the atypical neuroleptic, SDZ MAR 327. Int J Mol Med. 1998 Jan; 1(1):243-7.
    View in: PubMed
  93. Fischman AJ, Alpert NM, Babich JW, Rubin RH. The role of positron emission tomography in pharmacokinetic analysis. Drug Metab Rev. 1997 Nov; 29(4):923-56.
    View in: PubMed
  94. Rubin RH. Cytomegalovirus infection in the liver transplant recipient. Epidemiology, pathogenesis, and clinical management. Clin Liver Dis. 1997 Aug; 1(2):439-52, x.
    View in: PubMed
  95. George MJ, Snydman DR, Werner BG, Griffith J, Falagas ME, Dougherty NN, Rubin RH. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med. 1997 Aug; 103(2):106-13.
    View in: PubMed
  96. Edwards JE, Bodey GP, Bowden RA, Büchner T, de Pauw BE, Filler SG, Ghannoum MA, Glauser M, Herbrecht R, Kauffman CA, Kohno S, Martino P, Meunier F, Mori T, Pfaller MA, Rex JH, Rogers TR, Rubin RH, Solomkin J, Viscoli C, Walsh TJ, White M. International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis. 1997 Jul; 25(1):43-59.
    View in: PubMed
  97. Rubin RH, Fischman AJ. Positron emission tomography in drug development. Q J Nucl Med. 1997 Jun; 41(2):171-5.
    View in: PubMed
  98. Fischman AJ, Babich JW, Alpert NM, Vincent J, Wilkinson RA, Callahan RJ, Correia JA, Rubin RH. Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography. Clin Microbiol Infect. 1997 Feb; 3(1):63-72.
    View in: PubMed
  99. Strauss HW, Fischman AJ, Rubin RH. Radionuclide imaging of infection in soft tissue and bone. Curr Clin Top Infect Dis. 1997; 17:95-109.
    View in: PubMed
  100. Fischman AJ, Bonab AA, Babich JW, Alpert NM, Rauch SL, Elmaleh DR, Shoup TM, Williams SA, Rubin RH. Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone. J Pharmacol Exp Ther. 1996 Nov; 279(2):939-47.
    View in: PubMed
  101. Kelly KJ, Tolkoff-Rubin NE, Rubin RH, Williams WW, Meehan SM, Meschter CL, Christenson JG, Bonventre JV. An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury. Am J Physiol. 1996 Nov; 271(5 Pt 2):F1061-7.
    View in: PubMed
  102. Babich JW, Rubin RH, Graham WA, Wilkinson RA, Vincent J, Fischman AJ. 18F-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219). Nucl Med Biol. 1996 Nov; 23(8):995-8.
    View in: PubMed
  103. Rubin RH. Prevention of infection in the liver transplant recipient. Liver Transpl Surg. 1996 Sep; 2(5 Suppl 1):89-98.
    View in: PubMed
  104. Pascual M, Rubin RH, Cosimi AB. Minimizing the toxicity of antilymphocyte antibody therapy. Transplant Proc. 1996 Aug; 28(4):2113-4.
    View in: PubMed
  105. Fishman JA, Rubin RH, Koziel MJ, Periera BJ. Hepatitis C virus and organ transplantation. Transplantation. 1996 Jul 27; 62(2):147-54.
    View in: PubMed
  106. Rubin RH, Baltimore D, Chen BK, Wilkinson RA, Fischman AJ. In vivo tissue distribution of CD4 lymphocytes in mice determined by radioimmunoscintigraphy with an 111In-labeled anti-CD4 monoclonal antibody. Proc Natl Acad Sci U S A. 1996 Jul 23; 93(15):7460-3.
    View in: PubMed
  107. Patel R, Snydman DR, Rubin RH, Ho M, Pescovitz M, Martin M, Paya CV. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation. 1996 May 15; 61(9):1279-89.
    View in: PubMed
  108. Callahan RJ, Barrow SA, Abrams MJ, Rubin RH, Fischman AJ. Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG. J Nucl Med. 1996 May; 37(5):843-6.
    View in: PubMed
  109. Thaler SJ, Rubin RH. Opportunistic infections in the cardiac transplant patient. Curr Opin Cardiol. 1996 Mar; 11(2):191-203.
    View in: PubMed
  110. Fischman AJ, Livni E, Babich JW, Alpert NM, Bonab A, Chodosh S, McGovern F, Kamitsuka P, Liu YY, Cleeland R, Prosser BL, Correia JA, Rubin RH. Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography. Antimicrob Agents Chemother. 1996 Mar; 40(3):659-64.
    View in: PubMed
  111. Rubin RH, Fischman AJ. Radionuclide imaging of infection in the immunocompromised host. Clin Infect Dis. 1996 Mar; 22(3):414-23.
    View in: PubMed
  112. Kontoyiannis DP, Rubin RH. Infection in the organ transplant recipient. An overview. Infect Dis Clin North Am. 1995 Dec; 9(4):811-22.
    View in: PubMed
  113. Hibberd PL, Surman OS, Bass M, Tolkoff-Rubin NE, Cosimi AB, Schooley RT, Doran M, Delvecchio A, Rosal M, Rubin R. Psychiatric disease and cytomegalovirus viremia in renal transplant recipients. Psychosomatics. 1995 Nov-Dec; 36(6):561-3.
    View in: PubMed
  114. Haug CE, Lopez IA, Moore RH, Rubin RH, Tolkoff-Rubin N, Palacios de Caretta N, Colvin RB, Cosimi AB, Rabito CA. Real-time monitoring of renal function during ischemic injury in the rhesus monkey. Ren Fail. 1995 Sep; 17(5):489-502.
    View in: PubMed
  115. Palmer WE, Rosenthal DI, Schoenberg OI, Fischman AJ, Simon LS, Rubin RH, Polisson RP. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1995 Sep; 196(3):647-55.
    View in: PubMed
  116. Combes B, Carithers RL, Maddrey WC, Lin D, McDonald MF, Wheeler DE, Eigenbrodt EH, Muñoz SJ, Rubin R, Garcia-Tsao G, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 1995 Sep; 22(3):759-66.
    View in: PubMed
  117. Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, Snydman DR, Freeman R, Lorber MI, Rubin RH. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 1; 123(1):18-26.
    View in: PubMed
  118. Polisson RP, Schoenberg OI, Fischman A, Rubin R, Simon LS, Rosenthal D, Palmer WE. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum. 1995 Jun; 38(6):819-25.
    View in: PubMed
  119. Hanau C, Munoz SJ, Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology. 1995 Feb; 21(2):345-51.
    View in: PubMed
  120. Fischman AJ, Babich JW, Barrow SA, Graham W, Carter E, Tompkins RG, Rubin RH. Detection of acute bacterial infection within soft tissue injuries using a 99mTc-labeled chemotactic peptide. J Trauma. 1995 Feb; 38(2):223-7.
    View in: PubMed
  121. Basgoz N, Rubin RH. Antimicrobial prophylaxis in patients undergoing solid organ transplantation. Curr Clin Top Infect Dis. 1995; 15:344-64.
    View in: PubMed
  122. Livni E, Babich JW, Desai MC, Godek DM, Wilkinson RA, Rubin RH, Fischman AJ. Synthesis of a 11C-labeled NK1 receptor ligand for PET studies. Nucl Med Biol. 1995 Jan; 22(1):31-6.
    View in: PubMed
  123. Mischinger HJ, Hauser H, Rabl H, Quehenberger F, Werkgartner G, Rubin R, Deu E. Pyogenic liver abscess: studies of therapy and analysis of risk factors. World J Surg. 1994 Nov-Dec; 18(6):852-7; discussion 858.
    View in: PubMed
  124. Tolkoff-Rubin NE, Rubin RH. The interaction of immunosuppression with infection in the organ transplant recipient. Transplant Proc. 1994 Oct; 26(5 Suppl 1):16-9.
    View in: PubMed
  125. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis. 1994 Aug; 19 Suppl 1:S33-40.
    View in: PubMed
  126. Fischman AJ, Babich JW, Rubin RH. Infection imaging with technetium-99m-labeled chemotactic peptide analogs. Semin Nucl Med. 1994 Apr; 24(2):154-68.
    View in: PubMed
  127. Rubin RH, Fischman AJ. The use of radiolabeled nonspecific immunoglobulin in the detection of focal inflammation. Semin Nucl Med. 1994 Apr; 24(2):169-79.
    View in: PubMed
  128. Rabito CA, Panico F, Rubin R, Tolkoff-Rubin N, Teplick R. Noninvasive, real-time monitoring of renal function during critical care. J Am Soc Nephrol. 1994 Jan; 4(7):1421-8.
    View in: PubMed
  129. Rubin RH, Billingsley A, Caldwell CH. The role of the black church in working with black adolescents. Adolescence. 1994; 29(114):251-66.
    View in: PubMed
  130. Nohria A, Rubin RH. Cytokines as potential vaccine adjuvants. Biotherapy. 1994; 7(3-4):261-9.
    View in: PubMed
  131. Bonini PA, Alpert N, Luzzana M, Rubin R. Guidelines for the identification and distribution of patient samples in the medical laboratory. J Automat Chem. 1994; 16(1):25-32.
    View in: PubMed
  132. Fischman AJ, Solomon HF, Babich JW, Abrams MJ, Callahan RJ, Strauss HW, Rubin RH. Imaging of focal sites of inflammation in rhesus monkeys with 99mTc-labeled human polyclonal IgG. Nucl Med Biol. 1994 Jan; 21(1):111-6.
    View in: PubMed
  133. Rubin RH, Tolkoff-Rubin NE. Infection in the organ transplant patient; the Hegelian dialectic of transplantation. Trans Med Soc Lond. 1994-1995; 111:81-90.
    View in: PubMed
  134. Babich JW, Graham W, Barrow SA, Dragotakes SC, Tompkins RG, Rubin RH, Fischman AJ. Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit. J Nucl Med. 1993 Dec; 34(12):2176-81.
    View in: PubMed
  135. Fischman AJ, Rauh D, Solomon H, Babich JW, Tompkins RG, Kroon D, Strauss HW, Rubin RH. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. J Nucl Med. 1993 Dec; 34(12):2130-4.
    View in: PubMed
  136. Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, Rohrer RH, Freeman R, Jenkins R, Lewis WD, Hammer S, O'Rourke E, Grady GF, Fawaz K, Kaplan MM, Hoffman MA, Katz AT, Doran M. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1993 Nov 15; 119(10):984-91.
    View in: PubMed
  137. Barrow SA, Graham W, Jyawook S, Dragotakes SC, Solomon HF, Babich JW, Rubin RH, Fischman AJ. Localization of indium-111-immunoglobulin G, technetium-99m-immunoglobulin G and indium-111-labeled white blood cells at sites of acute bacterial infection in rabbits. J Nucl Med. 1993 Nov; 34(11):1975-9.
    View in: PubMed
  138. Babich JW, Solomon H, Pike MC, Kroon D, Graham W, Abrams MJ, Tompkins RG, Rubin RH, Fischman AJ. Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. J Nucl Med. 1993 Nov; 34(11):1964-74.
    View in: PubMed
  139. Mazzulli T, Rubin RH, Ferraro MJ, D'Aquila RT, Doveikis SA, Smith BR, The TH, Hirsch MS. Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol. 1993 Oct; 31(10):2824-7.
    View in: PubMed
  140. Wilz SW, Kurnick JT, Pandolfi F, Rubin RH, Warren HS, Goldstein R, Kersten CM, McCluskey RT. T lymphocyte responses to antigens of gram-negative bacteria in pyelonephritis. Clin Immunol Immunopathol. 1993 Oct; 69(1):36-42.
    View in: PubMed
  141. Rubin RH. The therapeutic prescription for the patient undergoing immunosuppressing therapy. Online J Curr Clin Trials. 1993 Sep 3; Doc No 86:[969 words; 7 paragraphs].
    View in: PubMed
  142. Hibberd PL, Rubin RH. Renal transplantation and related infections. Semin Respir Infect. 1993 Sep; 8(3):216-24.
    View in: PubMed
  143. Rubin RH, Ferraro MJ. Understanding and diagnosing infectious complications in the immunocompromised host. Current issues and trends. Hematol Oncol Clin North Am. 1993 Aug; 7(4):795-812.
    View in: PubMed
  144. Rubin RH. Infectious disease complications of renal transplantation. Kidney Int. 1993 Jul; 44(1):221-36.
    View in: PubMed
  145. Chen TY, Zapol WM, Greene E, Robinson DR, Rubin RH. Protective effects of E5, an antiendotoxin monoclonal antibody, in the ovine pulmonary circulation. J Appl Physiol. 1993 Jul; 75(1):233-9.
    View in: PubMed
  146. Fischman AJ, Alpert NM, Livni E, Ray S, Sinclair I, Callahan RJ, Correia JA, Webb D, Strauss HW, Rubin RH. Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother. 1993 Jun; 37(6):1270-7.
    View in: PubMed
  147. Rubin RH, Tolkoff-Rubin NE. Antimicrobial strategies in the care of organ transplant recipients. Antimicrob Agents Chemother. 1993 Apr; 37(4):619-24.
    View in: PubMed
  148. Rubin RH, Livni E, Babich J, Alpert NM, Liu YY, Tham E, Prosser B, Cleeland R, Callahan RJ, Correia JA, et al. Pharmacokinetics of fleroxacin as studied by positron emission tomography and [18F]fleroxacin. Am J Med. 1993 Mar 22; 94(3A):31S-37S.
    View in: PubMed
  149. Snydman DR, Rubin RH, Werner BG. New developments in cytomegalovirus prevention and management. Am J Kidney Dis. 1993 Feb; 21(2):217-28.
    View in: PubMed
  150. Rubin RH. Fungal and bacterial infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis. 1993; 12 Suppl 1:S42-8.
    View in: PubMed
  151. Livni E, Babich J, Alpert NM, Liu YY, Thom E, Cleeland R, Prosser BL, Correia JA, Strauss HW, Rubin RH, et al. Synthesis and biodistribution of 18F-labeled fleroxacin. Nucl Med Biol. 1993 Jan; 20(1):81-7.
    View in: PubMed
  152. Tolkoff-Rubin NE, Rubin RH. Viral infection in the renal transplant recipient. Curr Opin Nephrol Hypertens. 1992 Dec; 1(2):243-8.
    View in: PubMed
  153. Anaissie E, Gokaslan A, Hachem R, Rubin R, Griffin G, Robinson R, Sobel J, Bodey G. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis. 1992 Nov; 15(5):781-7.
    View in: PubMed
  154. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S216-27.
    View in: PubMed
  155. Hibberd PL, Tolkoff-Rubin NE, Doran M, Delvecchio A, Cosimi AB, Delmonico FL, Auchincloss H, Rubin RH. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial. Online J Curr Clin Trials. 1992 Aug 11; Doc No 15:[4083 words; 46 paragraphs].
    View in: PubMed
  156. Fischman AJ, Fucello AJ, Pellegrino-Gensey JL, Geltofsky J, Yarmush ML, Rubin RH, Strauss HW. Effect of carbohydrate modification on the localization of human polyclonal IgG at focal sites of bacterial infection. J Nucl Med. 1992 Jul; 33(7):1378-82.
    View in: PubMed
  157. Tolkoff-Rubin NE, Rubin RH. Clinical approach to viral and fungal infections in the renal transplant patient. Semin Nephrol. 1992 Jul; 12(4):364-75.
    View in: PubMed
  158. Rubin RH, Beam TR, Stamm WE. An approach to evaluating antibacterial agents in the treatment of urinary tract infection. Clin Infect Dis. 1992 Jun; 14 Suppl 2:S246-51; discussion S253-4.
    View in: PubMed
  159. Tolkoff-Rubin NE, Rubin RH. Opportunistic fungal and bacterial infection in the renal transplant recipient. J Am Soc Nephrol. 1992 Jun; 2(12 Suppl):S264-9.
    View in: PubMed
  160. Oyen WJ, Claessens RA, van der Meer JW, Rubin RH, Strauss HW, Corstens FH. Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci. Clin Infect Dis. 1992 May; 14(5):1110-8.
    View in: PubMed
  161. Juweid M, Strauss HW, Yaoita H, Rubin RH, Fischman AJ. Accumulation of immunoglobulin G at focal sites of inflammation. Eur J Nucl Med. 1992; 19(3):159-65.
    View in: PubMed
  162. Senda M, Fishman AJ, Weise S, Alpert NM, Correia JA, Rubin RH, Strauss HW. Regional perfusion, oxygen metabolism, blood volume and immunoglobulin G accumulation at focal sites of infection in rabbits. Eur J Nucl Med. 1992; 19(3):166-72.
    View in: PubMed
  163. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, Schooley RT, Isaacson D, Doran M, Delvecchio A, Delmonico FL, Auchincloss H, Rubin RH. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation. 1992 Jan; 53(1):68-72.
    View in: PubMed
  164. Rubin RH, Tolkoff-Rubin NE. The impact of infection on the outcome of transplantation. Transplant Proc. 1991 Aug; 23(4):2068-74.
    View in: PubMed
  165. Juweid M, Fischman AJ, Rubin RH, Baum R, Strauss HW. Comparison of 99Tcm-labelled monoclonal anti-granulocyte antibody and 111In-labelled IgG for the detection of focal sites of infection in rats. Nucl Med Commun. 1991 Jul; 12(7):637-44.
    View in: PubMed
  166. Rubin RH. Preemptive therapy in immunocompromised hosts. N Engl J Med. 1991 Apr 11; 324(15):1057-9.
    View in: PubMed
  167. Fischman AJ, Pike MC, Kroon D, Fucello AJ, Rexinger D, ten Kate C, Wilkinson R, Rubin RH, Strauss HW. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nucl Med. 1991 Mar; 32(3):483-91.
    View in: PubMed
  168. Fishman JA, Strauss HW, Fischman AJ, Nedelman M, Callahan R, Khaw BA, Rubin RH. Imaging of Pneumocystis carinii pneumonia with 111In-labelled non-specific polyclonal IgG: an experimental study in rats. Nucl Med Commun. 1991 Mar; 12(3):175-87.
    View in: PubMed
  169. Hibberd PL, Rubin RH. Prevention of cytomegalovirus infection in the pediatric renal transplant recipient. Pediatr Nephrol. 1991 Jan; 5(1):112-7.
    View in: PubMed
  170. Strauss HW, Fischman AJ, Khaw BA, Rubin RH. Non-tumor applications of radioimmune imaging. Int J Rad Appl Instrum B. 1991; 18(1):127-34.
    View in: PubMed
  171. Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, Fuccello AJ, Rubin RH, Strauss HW, Fischman AJ. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med. 1990 Dec; 31(12):2022-8.
    View in: PubMed
  172. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis. 1990 Sep-Oct; 12 Suppl 7:S754-66.
    View in: PubMed
  173. Fischman AJ, Rubin RH, White JA, Locke E, Wilkinson RA, Nedelman M, Callahan RJ, Khaw BA, Strauss HW. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med. 1990 Jul; 31(7):1199-205.
    View in: PubMed
  174. Tolkoff-Rubin NE, Rubin RH. Uremia and host defenses. N Engl J Med. 1990 Mar 15; 322(11):770-2.
    View in: PubMed
  175. Rubin RH, Johnson PC. Pulmonary infection in solid organ transplant recipients. Semin Respir Infect. 1990 Mar; 5(1):1.
    View in: PubMed
  176. Hibberd PL, Rubin RH. Approach to immunization in the immunosuppressed host. Infect Dis Clin North Am. 1990 Mar; 4(1):123-42.
    View in: PubMed
  177. Rubin RH. In search of the hot appendix--a clinician's view of inflammation imaging. J Nucl Med. 1990 Mar; 31(3):316-8.
    View in: PubMed
  178. Neu HC, Bennett JE, Bodey GP, Rubin RH, Schentag JJ, Sugar AM. P&T Committee review of fluconazole: an effective alternative to antifungal therapy. Hosp Formul. 1990 Mar; 25 Suppl B:9-14.
    View in: PubMed
  179. Tolkoff-Rubin NE, Conti DJ, Doran M, DelVecchio A, Rubin RH. Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients. Pharmacotherapy. 1990; 10(6 ( Pt 3)):159S-163S.
    View in: PubMed
  180. ten Kate CI, Fischman AJ, Rubin RH, Fucello AJ, Riexinger D, Wilkinson RA, Du L, Khaw BA, Strauss HW. Effect of isoelectric point on biodistribution and inflammation: imaging with indium-111-labelled IgG. Eur J Nucl Med. 1990; 17(6-8):305-9.
    View in: PubMed
  181. Rubin RH, Lynch P, Pasternack MS, Schoenfeld D, Medearis DN. Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice. Antimicrob Agents Chemother. 1989 Nov; 33(11):1975-9.
    View in: PubMed
  182. Rubin RH, Fischman AJ, Callahan RJ, Khaw BA, Keech F, Ahmad M, Wilkinson R, Strauss HW. 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med. 1989 Oct 5; 321(14):935-40.
    View in: PubMed
  183. Conti DJ, Tolkoff-Rubin NE, Baker GP, Doran M, Cosimi AB, Delmonico F, Auchincloss H, Russell PS, Rubin RH. Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. Transplantation. 1989 Oct; 48(4):692-5.
    View in: PubMed
  184. Morrell EM, Tompkins RG, Fischman AJ, Wilkinson RA, Burke JF, Rubin RH, Strauss HW, Yarmush ML. Autoradiographic method for quantitation of radiolabeled proteins in tissues using indium-111. J Nucl Med. 1989 Sep; 30(9):1538-45.
    View in: PubMed
  185. Rubin RH, Wilkinson RA, Xu L, Robinson DR. Dietary marine lipid does not alter susceptibility of (NZBxNZW)F1 mice to pathogenic microorganisms. Prostaglandins. 1989 Aug; 38(2):251-62.
    View in: PubMed
  186. LaMuraglia GM, Fischman AJ, Strauss HW, Keech F, Wilkinson R, Callahan RJ, Khaw BA, Rubin RH. Utility of the indium 111-labeled human immunoglobulin G scan for the detection of focal vascular graft infection. J Vasc Surg. 1989 Jul; 10(1):20-7; discussion 27-8.
    View in: PubMed
  187. Hibberd PL, Rubin RH. Immunization strategies for the immunocompromised host: the need for immunoadjuvants. Ann Intern Med. 1989 Jun 15; 110(12):955-6.
    View in: PubMed
  188. Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA. 1989 Jun 23-30; 261(24):3607-9.
    View in: PubMed
  189. Fischman AJ, Rubin RH, Khaw BA, Kramer PB, Wilkinson R, Ahmad M, Needelman M, Locke E, Nossiff ND, Strauss HW. Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G. J Nucl Med. 1989 Jun; 30(6):1095-100.
    View in: PubMed
  190. Rubin RH, Fischman AJ, Needleman M, Wilkinson R, Callahan RJ, Khaw BA, Hansen WP, Kramer PB, Strauss HW. Radiolabeled, nonspecific, polyclonal human immunoglobulin in the detection of focal inflammation by scintigraphy: comparison with gallium-67 citrate and technetium-99m-labeled albumin. J Nucl Med. 1989 Mar; 30(3):385-9.
    View in: PubMed
  191. Senda M, Ahmad M, Rubin R, Strauss HW. Thallium 201 uptake in kidneys and heart as an indicator of prognosis in septic shock in the rat. Circ Shock. 1989 Mar; 27(3):211-7.
    View in: PubMed
  192. Arthur M, Johnson CE, Rubin RH, Arbeit RD, Campanelli C, Kim C, Steinbach S, Agarwal M, Wilkinson R, Goldstein R. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun. 1989 Feb; 57(2):303-13.
    View in: PubMed
  193. Rubin RH, Tolkoff-Rubin NE. Infection: the new problems. Transplant Proc. 1989 Feb; 21(1 Pt 2):1440-5.
    View in: PubMed
  194. Arthur M, Campanelli C, Arbeit RD, Kim C, Steinbach S, Johnson CE, Rubin RH, Goldstein R. Structure and copy number of gene clusters related to the pap P-adhesin operon of uropathogenic Escherichia coli. Infect Immun. 1989 Feb; 57(2):314-21.
    View in: PubMed
  195. Hopkins CC, Weber DJ, Rubin RH. Invasive aspergillus infection: possible non-ward common source within the hospital environment. J Hosp Infect. 1989 Jan; 13(1):19-25.
    View in: PubMed
  196. Fishman JA, Strauss HW, Nedelman M, Callahan R, Khaw BA, Rubin RH. Noninvasive diagnosis of Pneumocystis carinii in the rat using radiolabeled, nonspecific, human polyclonal immunoglobulin. J Protozool. 1989 Jan-Feb; 36(1):46S-47S.
    View in: PubMed
  197. Rubin RH, Tolkoff-Rubin NE. Post transfusion viral infections. Transplant Proc. 1988 Dec; 20(6):1112-7.
    View in: PubMed
  198. Rubin RH, Tolkoff-Rubin NE. Opportunistic infections in renal allograft recipients. Transplant Proc. 1988 Dec; 20(6 Suppl 8):12-8.
    View in: PubMed
  199. Kurnick JT, McCluskey RT, Bhan AK, Wright KA, Wilkinson R, Rubin RH. Escherichia coli-specific T lymphocytes in experimental pyelonephritis. J Immunol. 1988 Nov 1; 141(9):3220-6.
    View in: PubMed
  200. Fischman AJ, Rubin RH, Khaw BA, Callahan RJ, Wilkinson R, Keech F, Nedelman M, Dragotakes S, Kramer PB, LaMuraglia GM, et al. Detection of acute inflammation with 111In-labeled nonspecific polyclonal IgG. Semin Nucl Med. 1988 Oct; 18(4):335-44.
    View in: PubMed
  201. Goldberg MB, Rubin RH. The spectrum of Salmonella infection. Infect Dis Clin North Am. 1988 Sep; 2(3):571-98.
    View in: PubMed
  202. Tolkoff-Rubin NE, Rubin RH, Bonventre JV. Noninvasive renal diagnostic studies. Clin Lab Med. 1988 Sep; 8(3):507-26.
    View in: PubMed
  203. Andrews CA, Shah KV, Daniel RW, Hirsch MS, Rubin RH. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis. 1988 Jul; 158(1):176-81.
    View in: PubMed
  204. Rubin RH, Young LS, Hansen WP, Nedelman M, Wilkinson R, Nelles MJ, Callahan R, Khaw BA, Strauss HW. Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J Nucl Med. 1988 May; 29(5):651-6.
    View in: PubMed
  205. Conti DJ, Rubin RH. Infection of the central nervous system in organ transplant recipients. Neurol Clin. 1988 May; 6(2):241-60.
    View in: PubMed
  206. Cosimi AB, Auchincloss H, Delmonico FL, Fang L, Nathan DM, Tolkoff-Rubin N, Rubin RH, Yang HC, Russell PS. Combined kidney and pancreas transplantation in diabetics. Arch Surg. 1988 May; 123(5):621-5.
    View in: PubMed
  207. Rubin RH, Tolkoff-Rubin NE. The problem of human immunodeficiency virus (HIV) infection and transplantation. Transpl Int. 1988 Apr; 1(1):36-42.
    View in: PubMed
  208. Rubin RH. Empiric antibacterial therapy in granulocytopenia induced by cancer chemotherapy. Ann Intern Med. 1988 Jan; 108(1):134-6.
    View in: PubMed
  209. Delmonico FL, Auchincloss H, Rubin RH, Russell PS, Tolkoff-Rubin N, Fang LT, Cosimi AB. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction. Ann Surg. 1987 Nov; 206(5):649-54.
    View in: PubMed
  210. Rubin RH. The compromised host as sentinel chicken. N Engl J Med. 1987 Oct 29; 317(18):1151-3.
    View in: PubMed
  211. Tuazon TV, Schneeberger EE, Bhan AK, McCluskey RT, Cosimi AB, Schooley RT, Rubin RH, Colvin RB. Mononuclear cells in acute allograft glomerulopathy. Am J Pathol. 1987 Oct; 129(1):119-32.
    View in: PubMed
  212. Wilson EJ, Medearis DN, Hansen LA, Rubin RH. 9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice. Antimicrob Agents Chemother. 1987 Jul; 31(7):1017-20.
    View in: PubMed
  213. Ildstad ST, Cosimi AB, Delmonico FL, Fuller TC, Tolkoff-Rubin N, Rubin RH, Russell PS. Renal transplantation in the highly sensitized recipient. Transplant Proc. 1987 Feb; 19(1 Pt 1):769-70.
    View in: PubMed
  214. Rubin RH, Peterson PK. Overview of pneumonia in the compromised host. Semin Respir Infect. 1986 Sep; 1(3):131-2.
    View in: PubMed
  215. Schooley RT, Carey RW, Miller G, Henle W, Eastman R, Mark EJ, Kenyon K, Wheeler EO, Rubin RH. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med. 1986 May; 104(5):636-43.
    View in: PubMed
  216. Tolkoff-Rubin NE, Rubin RH. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient. Transplant Proc. 1986 Apr; 18(2 Suppl 1):168-76.
    View in: PubMed
  217. Jacobson IM, Dienstag JL, Zachoval R, Hanrahan BA, Watkins E, Rubin RH. Lack of effect of hepatitis B vaccine on T-cell phenotypes. N Engl J Med. 1984 Oct 18; 311(16):1030-2.
    View in: PubMed
  218. Hirsch MS, Schooley RT, Cosimi AB, Russell PS, Delmonico FL, Tolkoff-Rubin NE, Herrin JT, Cantell K, Farrell ML, Rota TR, Rubin RH. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med. 1983 Jun 23; 308(25):1489-93.
    View in: PubMed
  219. Schooley RT, Hirsch MS, Colvin RB, Cosimi AB, Tolkoff-Rubin NE, McCluskey RT, Burton RC, Russell PS, Herrin JT, Delmonico FL, Giorgi JV, Henle W, Rubin RH. Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med. 1983 Feb 10; 308(6):307-13.
    View in: PubMed
  220. Tolkoff-Rubin NE, Cosimi AB, Russell PS, Rubin RH. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis. 1982 Mar-Apr; 4(2):614-8.
    View in: PubMed
  221. Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen WP, Delmonico FL, Russell PS. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med. 1981 Aug 6; 305(6):308-14.
    View in: PubMed
  222. Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, Rubin RH. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981 Jul 9; 305(2):57-63.
    View in: PubMed
  223. Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkoff-Rubin N. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med. 1981 Apr 16; 304(16):934-9.
    View in: PubMed
  224. Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE. Infection in the renal transplant recipient. Am J Med. 1981 Feb; 70(2):405-11.
    View in: PubMed
  225. Rubin RH, Cosimi AB, Hirsch MS, Herrin JT, Russell PS, Tolkoff-Rubin NE. Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation. 1981 Feb; 31(2):143-5.
    View in: PubMed
  226. Rubin RH, Swartz MN. Trimethoprim-sulfamethoxazole. N Engl J Med. 1980 Aug 21; 303(8):426-32.
    View in: PubMed
  227. Rubin RH, Fang LS, Jones SR, Munford RS, Slepack JM, Varga PA, Onheiber L, Hall CL, Tolkoff-Rubin NE. Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique. JAMA. 1980 Aug 8; 244(6):561-64.
    View in: PubMed
  228. Cheeseman SH, Henle W, Rubin RH, Tolkoff-Rubin NE, Cosimi B, Cantell K, Winkle S, Herrin JT, Black PH, Russell PS, Hirsch MS. Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon. Ann Intern Med. 1980 Jul; 93(1):39-42.
    View in: PubMed
  229. Ramsey PG, Rubin RH, Tolkoff-Rubin NE, Cosimi AB, Russell PS, Greene R. The renal transplant patient with fever and pulmonary infiltrates: etiology, clinical manifestations, and management. Medicine (Baltimore). 1980 May; 59(3):206-22.
    View in: PubMed
  230. Cheeseman SH, Rubin RH, Stewart JA, Tolkoff-Rubin NE, Cosimi AB, Cantell K, Gilbert J, Winkle S, Herrin JT, Black PH, Russell PS, Hirsch MS. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med. 1979 Jun 14; 300(24):1345-9.
    View in: PubMed
  231. Tolkoff-Rubin NA, Rubin RH, Keller EE, Baker GP, Stewart JA, Hirsch MS. Cytomegalovirus infection in dialysis patients and personnel. Ann Intern Med. 1978 Nov; 89(5 Pt 1):625-8.
    View in: PubMed
  232. Pruitt AA, Rubin RH, Karchmer AW, Duncan GW. Neurologic complications of bacterial endocarditis. Medicine (Baltimore). 1978 Jul; 57(4):329-43.
    View in: PubMed
  233. Tolkoff-Rubin NE, Fisher SL, O'Brien JT, Rubin RH. Coordinated home care: the Massachusetts General Hospital experience. Med Care. 1978 Jun; 16(6):453-64.
    View in: PubMed
  234. Fang LS, Tolkoff-Rubin NE, Rubin RH. Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. N Engl J Med. 1978 Feb 23; 298(8):413-6.
    View in: PubMed
  235. Rubin RH, Cosimi AB, Tolkoff-Rubin NE, Russell PS, Hirsch MS. Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation. 1977 Dec; 24(6):458-64.
    View in: PubMed
  236. Keller EW, Rubin RH, Black PH, Hirsch MS, Hierholzer JC. Isolation of adenovirus type 34 from a renal transplant recipient with interstitial pneumonia. Transplantation. 1977 Feb; 23(2):188-91.
    View in: PubMed
  237. Rubin RH, Swartz MN, Malt R. Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects. Am J Med. 1974 Oct; 57(4):601-10.
    View in: PubMed
  238. Hattwick MA, Rubin RH, Music S, Sikes RK, Smith JS, Gregg MB. Postexposure rabies prophylaxis with human rabies immune globulin. JAMA. 1974 Jan 28; 227(4):407-10.
    View in: PubMed
  239. Rubin RH, Sikes RK, Gregg MB. Human rabies immune globulin. Clinical trials and effects on serum anti- -globulins. JAMA. 1973 May 7; 224(6):871-4.
    View in: PubMed
  240. Rubin RH, Hattwick MA, Jones S, Gregg MB, Schwartz VD. Adverse reactions to duck embryo rabies vaccine. Range and incidence. Ann Intern Med. 1973 May; 78(5):643-9.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Rubin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_